Sylvamo CORP

Market Movers (8-K)

NYSE
Sylvamo Corporation's annual meeting on May 15, 2026, saw the election of seven directors, ratification of its auditor, and approval of executive compensation.
NYSE
Sylvamo Corporation announced its first quarter 2026 financial results, reporting a net loss of $3 million and adjusted EBITDA of $29 million, impacted by capacity constraints and strategic investments.
Worse than expected
NYSE
Sylvamo Corporation announced its fourth quarter and full year 2025 financial results, revealing lower net income and adjusted EBITDA compared to the prior year, alongside strategic investments and capital returns.
Delay expected
Worse than expected
NYSE
Sylvamo Corporation announces the retirement of its CEO and Chairman, Jean-Michel Ribiras, and the appointments of John V. Sims as CEO and President, and David Petratis as independent Chairman, effective January 1, 2026.
NYSE
Sylvamo Corporation's board unanimously adopted a limited-duration shareowner rights plan to protect shareholder value following the termination of a cooperation agreement with Atlas Holdings.
NYSE
Sylvamo reported strong third-quarter 2025 results with 7% sales volume growth quarter-over-quarter, improved operational performance, and significant cash returns to shareowners.
Capital raise
Better than expected

Quarterly Earnings (10-Q)

NYSE
Sylvamo Corporation reported a net loss of $3 million for the first quarter of 2026, a significant decrease from the prior year's net income, driven by lower sales and increased operational costs.
Worse than expected
NYSE
Sylvamo Corporation reported a significant decline in net income and sales for Q3 2025, driven by lower volumes and unfavorable pricing, particularly in Europe and North America.
Delay expected
Worse than expected
NYSE
Sylvamo Corporation reported a significant decline in second-quarter net income and sales, driven by lower volumes, unfavorable pricing, and increased maintenance costs.
Worse than expected
NYSE
Sylvamo Corporation's Q1 2025 net income decreased to $27 million ($0.65 per diluted share) from $43 million ($1.02 per diluted share) in Q1 2024, with net sales declining to $821 million from $905 million.
Worse than expected
NYSE
Sylvamo Corporation's Q3 2024 results show a significant increase in net income and sales compared to the same period last year, driven by higher sales volumes and effective cost management.
Better than expected
NYSE
Sylvamo Corporation's second quarter 2024 net income increased to $83 million, driven by improved pricing and higher sales volumes.
Better than expected

Annual Reports (10-K)

NYSE
Sylvamo Corporation's 2024 10-K filing reveals increased net income and sales, driven by strong demand and effective cost management.
NYSE
Sylvamo Corporation's 10-K filing outlines the rights of its capital stock, compliance with regulations, and various risk factors impacting the business.
Worse than expected

Insider Trading (Form 4)

NYSE
James P. Zallie, a Director of Sylvamo Corp, received 45 shares of common stock on July 28, 2026.
NYSE
David D Petratis, a Director of Sylvamo Corp, received 464 shares of common stock on July 28, 2026.
NYSE
Joia M Johnson, a Director of Sylvamo Corp, reported multiple transactions in common stock on July 28, 2026.
NYSE
Jeanmarie F. Desmond, a Director of Sylvamo Corp, received 136 shares of common stock on July 28, 2026.
NYSE
Lizanne M Bruce, a Director of Sylvamo Corp, received 45 shares of common stock on July 28, 2026.
NYSE
Christine S Breves, a Director of Sylvamo Corp, reported multiple transactions in common stock on July 28, 2026.

Proxy Statements (Def-14A)

NYSE
Sylvamo Corporation outlines its 2026 Annual Meeting proposals, reflects on challenging 2025 financial results, and presents a refined long-term strategic vision.
Delay expected
Worse than expected
NYSE
Sylvamo Corporation announces the retirement of Chairman and CEO Jean-Michel Ribiras, effective December 31, 2025, and the appointment of John Sims as Chief Operating Officer, set to become the next CEO on January 1, 2026.
NYSE
Sylvamo Corporation will hold its annual meeting of stockholders on May 15, 2025, featuring proposals for director elections, auditor ratification, and executive compensation approval.
NYSE
Sylvamo Corporation's proxy statement details proposals for the 2025 annual meeting, including director elections, auditor ratification, and executive compensation approval.
Better than expected
NYSE
Sylvamo Corporation will hold its annual shareholders meeting on May 16, 2024, to elect directors, ratify the appointment of Deloitte & Touche LLP, approve executive compensation, and approve an amendment to the company's certificate of incorporation.
NYSE
Sylvamo Corporation's 2024 proxy statement outlines proposals for the annual meeting, including director elections, auditor ratification, executive compensation approval, and a charter amendment regarding officer liability.

Schedule 13D - Activist Investments

NYSE
Atlas Group has terminated its cooperation agreement with Sylvamo Corporation, leading to the resignation of two directors and signaling potential strategic shifts.
Capital raise

Schedule 13G - Passive Investments

NYSE
The Vanguard Group reported a 0% beneficial ownership in Sylvamo Corp common stock following an internal realignment, with subsidiaries now reporting separately.
NYSE
Millennium Management LLC and affiliated entities report a 5.4% passive beneficial ownership stake in Sylvamo Corporation's common stock.
NYSE
Nomura Holdings Inc. and its subsidiary Nomura Global Financial Products, Inc. reported a 4% beneficial ownership stake in Sylvamo Corp. as of June 30, 2025.
NYSE
The Vanguard Group has filed an amendment to its Schedule 13G, reporting a 7.51% beneficial ownership stake in Sylvamo Corp's common stock as of June 30, 2025.
NYSE
Nomura Holdings Inc. and its subsidiaries have filed an amended Schedule 13G, reporting a passive beneficial ownership of 7.3% in Sylvamo Corp.'s common stock as of December 31, 2024.